The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19
Open Access
- 21 September 2022
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 11 (10) , 1862
Abstract
The pandemic of COVID-19 was caused by a novel coronavirus termed as SARS-CoV2 and is still ongoing with high morbidity and mortality rates in the whole world. The pathogenesis of COVID-19 is highly linked with over-active immune and inflammatory responses, leading to activated cytokine storm, which contribute to ARDS with worsen outcome. Currently, there is no effective therapeutic drug for the treatment of COVID-19. Zinc is known to act as an immune modulator, which plays an important role in immune defense system. Recently, zinc has been widely considered as an anti-inflammatory and anti-oxidant agent. Accumulating numbers of studies have revealed that zinc plays an important role in antiviral immunity in several viral infections. Several early clinical trials clearly indicate that zinc treatment remarkably decreased the severity of the upper respiratory infection of rhinovirus in humans. Currently, zinc has been used for the therapeutic intervention of COVID-19 in many different clinical trials. Several clinical studies reveal that zinc treatment using a combination of HCQ and zinc pronouncedly reduced symptom score and the rates of hospital admission and mortality in COVID-19 patients. These data support that zinc might act as an anti-viral agent in the addition to its anti-inflammatory and anti-oxidant properties for the adjuvant therapeutic intervention of COVID-19.Keywords
This publication has 194 references indexed in Scilit:
- Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceCurrent Opinion in Virology, 2011
- Intracellular free zinc up-regulates IFN-γ and T-bet essential for Th1 differentiation in Con-A stimulated HUT-78 cellsBiochemical and Biophysical Research Communications, 2011
- Natural Killer Cell Responses to Viral InfectionJournal of Innate Immunity, 2011
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLOS Pathogens, 2010
- Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agentThe American Journal of Clinical Nutrition, 2010
- The Essential Toxin: Impact of Zinc on Human HealthInternational Journal of Environmental Research and Public Health, 2010
- Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patientsTranslational Research, 2008
- Human immunopathogenesis of severe acute respiratory syndrome (SARS)Virus Research, 2008
- Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivityBiochemical and Biophysical Research Communications, 2007
- Zinc-induced anemia and neutropenia in an adolescentThe Journal of Pediatrics, 2000